Michael Geffner
Chief Tech/Sci/R&D Officer at IMMUNOVANT, INC.
Net worth: 4 M $ as of 29/04/2024
Profile
Michael Geffner is currently the Chief Medical Officer at Immunovant, Inc. He previously worked as the Senior VP-Development & Medical Affairs at Achillion Pharmaceuticals, Inc. He holds an MBA from Fairleigh Dickinson University and a doctorate from Albany Medical College.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
IMMUNOVANT INC
0.10% | 23/04/2024 | 141,616 ( 0.10% ) | 4 M $ | 29/04/2024 |
Michael Geffner active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOVANT, INC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Michael Geffner
| Companies | Position | End |
|---|---|---|
| ACHILLION PHARMACEUTICALS, INC. | Corporate Officer/Principal | 27/01/2020 |
Training of Michael Geffner
| Albany Medical College | Doctorate Degree |
| Fairleigh Dickinson University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| IMMUNOVANT, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
- Stock Market
- Insiders
- Michael Geffner